MAINZ BIOMED N.V. (NASDAQ:MYNZ) filed a Form 8-K with the Securities and Exchange Commission on February 10, 2026, disclosing a material event.
MAINZ BIOMED N.V.'s stock currently trades at $0.90 with a market capitalization of $4.3M. The Healthcare company's stock moved following the disclosure.